CPRX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Catalyst Pharmaceuticals Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Mar 31, 2026	-32,926,000
Dec 31, 2025	-16,994,000
Sep 30, 2025	13,019,000
Jun 30, 2025	2,391,000
Mar 31, 2025	2,676,000
Dec 31, 2024	140,665,000
Sep 30, 2024	135,567,000
Jun 30, 2024	131,414,000
Mar 31, 2024	130,043,000
Dec 31, 2023	-10,857,000
Sep 30, 2023	-7,939,000
Jun 30, 2023	6,172,000
Mar 31, 2023	3,394,000
Dec 31, 2022	1,694,000
Sep 30, 2022	-3,085,000
Jun 30, 2022	-9,167,000
Mar 31, 2022	-9,882,000
Dec 31, 2021	-8,143,000
Sep 30, 2021	-5,591,431
Jun 30, 2021	-2,879,417
Mar 31, 2021	863,784
Dec 31, 2020	701,933
Sep 30, 2020	1,254,644
Jun 30, 2020	896,692
Mar 31, 2020	1,053,041
Dec 31, 2019	1,116,242
Sep 30, 2019	689,461
Jun 30, 2019	537,931
Mar 31, 2019	349,433
Dec 31, 2018	293,115
Sep 30, 2018	54,278,411
Jun 30, 2018	55,581,815
Mar 31, 2018	57,383,200
Dec 31, 2017	57,350,168
Sep 30, 2017	3,293,624
Jun 30, 2017	1,885,688
Mar 31, 2017	80,251
Dec 31, 2016	68,986
Sep 30, 2016	54,137
Jun 30, 2016	970,754
Mar 31, 2016	1,083,798
Dec 31, 2015	37,159,958
Sep 30, 2015	38,916,556
Jun 30, 2015	37,999,939
Mar 31, 2015	64,612,025
Dec 31, 2014	28,563,634
Sep 30, 2014	26,931,435
Jun 30, 2014	44,896,628
Mar 31, 2014	18,194,998
Dec 31, 2013	18,178,494
Sep 30, 2013	23,071,327
Jun 30, 2013	10,666,086
Mar 31, 2013	14,580,889
Dec 31, 2012	14,580,889
Sep 30, 2012	12,812,199
Jun 30, 2012	7,252,247
Mar 31, 2012	3,313,944
Dec 31, 2011	5,542,578
Sep 30, 2011	5,926,769
Jun 30, 2011	7,382,922
Mar 31, 2011	7,382,922
Dec 31, 2010	5,154,288
Sep 30, 2010	5,154,288
Jun 30, 2010	3,698,135
Mar 31, 2010	3,698,135
Dec 31, 2009	3,698,135
Sep 30, 2009	-360,102
Jun 30, 2009	4,103,494
Mar 31, 2009	4,086,500
Dec 31, 2008	4,084,490
Sep 30, 2008	4,444,592
Jun 30, 2008	-19,004
Mar 31, 2008	-2,010
Dec 31, 2007	0
Sep 30, 2007	18,110,094
Jun 30, 2007	20,863,160